Medisys buys Lukens Medical for $12.4 million:
This article was originally published in Clinica
Medisys, the UK-based point-of-care device company, has agreed to pay $12.4 million for Lukens Medical, a wound closure and suture company. Nasdaq-quoted Lukens was founded in 1906 and has recently diversified into sharps disposal and lancets used in diabetes testing. Medisys regards the purchase as a cost-effective way to penetrate the US market. Medisys' diabetes subsidiary Hypoguard has been hit by increased competition and delays in new product launches.